Evidence map›Paper›PMID 34461140›Full record

ArticleDiabetes research and clinical practice2021

The effect of the COVID-19 pandemic on telemedicine in pediatric diabetes centers in Italy: Results from a longitudinal survey.

Gianluca Tornese, Riccardo Schiaffini, Enza Mozzillo, Roberto Franceschi, Anna Paola Frongia, Andrea Scaramuzza, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes

Abstract read
In one paragraph

Article in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Review
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gianluca TorneseInstitute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
Riccardo SchiaffiniDiabetes Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Enza MozzilloDepartment of Translational Medical Science, Section of Pediatrics, Regional Center for Pediatric Diabetes, University of Naples Federico II, Naples, Italy.
Roberto FranceschiDepartment of Pediatrics, Santa Chiara Hospital Trento, Trento, Italy.
Anna Paola FrongiaUnit of Pediatric Diabetes, Brotzu Hospital, Cagliari, Italy.
Andrea ScaramuzzaDivision of Pediatrics, ASST Cremona, "Ospedale Maggiore di Cremona", Viale Concordia 1, 26100 Cremona, Italy. Electronic address: andrea.scaramuzza@asst-cremona.it.
Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIn March and April 2020, at the start of the COVID-19 pandemic, our previous survey of Italian pediatric diabetes centers showed that 75% of telemedicine use was voluntary. We hypothesized that the COVID-19 pandemic has acted as a picklock to overcome barriers to telemedicine regulation, use, and reimbursement.

methodsBetween March 22nd and April 12th, 2021, the same survey administered in 2020 was sent to all 68 Italian pediatric diabetes centers belonging to the Italian Society for Pediatric Endocrinology and Diabetes (ISPED) to collect data on the demographic variables of respondents; information about the center; the use, codification, and reimbursement of telemedicine; and used tools. Descriptive data were evaluated to establish how the COVID-19 pandemic has changed telemedicine practice.

resultsEighty-two percent of responder centers reported an increase in the use of telemedicine, with televisits by video calling implemented in over half of centers. There was a significant increase in the number of centers formally tracking telemedicine use and obtaining reimbursement from the national health service (42% vs. 29% and 62% vs. 32%; p < 0.001, respectively). No reimbursement was provided to centers not using televisits.

conclusionsFrom a voluntary procedure with a lack of traceability, telemedicine has become a new structured reality that may help our pediatric patients beyond this pandemic.

Indexed as

COVID-19Diabetes MellitusTelemedicineChildHumansItalyLongitudinal StudiesPandemicsSARS-CoV-2State MedicineContinuous glucose monitoringContinuous subcutaneous insulin infusionInsulin pumpPediatric diabetesTelemedicine

Identifiers

PMID34461140
PMCPMC8438313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.